May 25, 1994

The Importance of Placebo Effects in Pain Treatment and Research

Author Affiliations

From the Departments of Psychiatry and Behavioral Sciences (Dr Turner), Rehabilitation Medicine (Drs Turner and Fordyce), Medicine (Dr Deyo), Health Services (Dr Deyo), Neurological Surgery (Dr Loeser), and Anesthesiology (Dr Loeser), and the Multidisciplinary Pain Center (Drs Turner and Loeser), University of Washington, Seattle; the Health Services Research and Development Field Program, Veterans Affairs Medical Center, Seattle (Dr Deyo); and the Center for Health Studies, Group Health Cooperative of Puget Sound, Seattle (Dr Von Korff).

JAMA. 1994;271(20):1609-1614. doi:10.1001/jama.1994.03510440069036

Objective.  —To estimate the importance and implications of placebo effects in pain treatment and research from the existing literature, with emphasis on their magnitude and duration, the conditions influencing them, and proposed explanations.

Data Sources.  —English-language articles and books identified through MEDLINE (1980 through 1993) and PsycLIT (1967 through 1993) database searching, bibliography review, and expert consultation.

Study Selection.  —Articles were included if they pertained to the review objectives.

Results.  —Placebo response rates vary greatly and are frequently much higher than the often-cited one third. Placebos have time-effect curves, and peak, cumulative, and carryover effects similar to those of active medications. As with medication, surgery can produce substantial placebo effects, and this possibility is commonly overlooked in case series reports on back surgery. Individuals are not consistent in their placebo responses, and a placebo-responder personality has not been identified. Models advanced to explain placebo effects emphasize the role of anxiety, expectations, and learning.

Conclusions.  —Placebo effects influence patient outcomes after any treatment, including surgery, that the clinician and patient believe is effective. Placebo effects plus disease natural history and regression to the mean can result in high rates of good outcomes, which may be misattributed to specific treatment effects. The true causes of improvements in pain after treatment remain unknown in the absence of independently evaluated randomized controlled trials.(JAMA. 1994;271:1609-1614)